Success Metrics

Clinical Success Rate
100.0%

Based on 10 completed trials

Completion Rate
100%(10/10)
Active Trials
0(0%)
Results Posted
80%(8 trials)

Phase Distribution

Ph phase_2
4
36%
Ph phase_3
6
55%
Ph phase_1
1
9%

Phase Distribution

1

Early Stage

4

Mid Stage

6

Late Stage

Phase Distribution11 total trials
Phase 1Safety & dosage
1(9.1%)
Phase 2Efficacy & side effects
4(36.4%)
Phase 3Large-scale testing
6(54.5%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

10 of 10 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

11

all time

Status Distribution
Completed(10)
Other(1)

Detailed Status

Completed10
unknown1

Development Timeline

Analytics

Development Status

Total Trials
11
Active
0
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 11 (9.1%)
Phase 24 (36.4%)
Phase 36 (54.5%)

Trials by Status

completed1091%
unknown19%

Recent Activity

0 active trials
Showing 5 of 11
completedphase_2

RTA 408 Lotion in Patients at Risk for Radiation Dermatitis - PRIMROSE

NCT02142959
completedphase_3

A Comparison of DFD01 Spray Versus Comp01 Lotion, Vehicle Spray and Vehicle Lotion in Subjects With Moderate Psoriasis

NCT01947491
completedphase_2

Ovicidal Efficacy and Safety of Abametapir Lotion 0.74% Administered for the Treatment of Head Lice Infestation

NCT02097485
completedphase_3

A Study of the Efficacy and Safety of Abametapir Lotion Administered for the Treatment of Head Lice Infestation

NCT02060903
completedphase_2

Safety and Efficacy of IDP-123 Lotion to Tazorac® Cream, in the Treatment of Acne Vulgaris

NCT02938494
View all 11 trials

Clinical Trials (11)

Showing 11 of 11 trials
NCT02142959Phase 2

RTA 408 Lotion in Patients at Risk for Radiation Dermatitis - PRIMROSE

Completed
NCT01947491Phase 3

A Comparison of DFD01 Spray Versus Comp01 Lotion, Vehicle Spray and Vehicle Lotion in Subjects With Moderate Psoriasis

Completed
NCT02097485Phase 2

Ovicidal Efficacy and Safety of Abametapir Lotion 0.74% Administered for the Treatment of Head Lice Infestation

Completed
NCT02060903Phase 3

A Study of the Efficacy and Safety of Abametapir Lotion Administered for the Treatment of Head Lice Infestation

Completed
NCT02938494Phase 2

Safety and Efficacy of IDP-123 Lotion to Tazorac® Cream, in the Treatment of Acne Vulgaris

Completed
NCT02062060Phase 3

Study of the Efficacy and Safety of Abametapir Lotion Administered for the Treatment of Head Lice Infestation

Completed
NCT02062073Phase 1

Dermal Safety Study to Evaluate the Sensitizing Potential of Abametapir Lotion

Completed
NCT03301649Phase 3

Clinical Endpoint Study of Ivermectin 0.5% Lotion

Completed
NCT01882647Phase 3

A Comparison of 000-0551 Lotion Versus Vehicle Lotion in Subjects With Plaque Psoriasis (Study -305)

Completed
NCT01871402Phase 3

A Comparison of 000-0551 Lotion Versus Vehicle Lotion in Subjects With Plaque Psoriasis (Study -304)

Completed
NCT02525822Phase 2

Study to Compare the Safety and Efficacy of IDP-123 Lotion to Tazorac Cream in the Treatment of Acne Vulgaris

Unknown

All 11 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
11